Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphate restriction in diet therapy.

Eiji Takeda1, Hironori Yamamoto, Yuka Nishida

  • 1Department of Clinical Nutrition, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan.

Contributions to Nephrology
|March 21, 2007
PubMed
Summary

Managing phosphorus and protein intake is crucial for patients with end-stage renal disease to prevent complications. Dietary phosphorus restriction and appropriate protein intake slow renal failure progression and improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between Vitamin D nutrition status and physical functions in latter stage elderly at nursing home.

The journal of medical investigation : JMI·2026
Same author

Daily Energy and Protein Intake Requirements to Prevent Body Weight Loss in Elderly Residents of Nursing Homes.

Cureus·2025
Same author

Effects of vitamin D on muscle mass and function in high school athletes.

The journal of medical investigation : JMI·2025
Same author

Assessment of water balance in high school athletes and non-athletes.

The journal of medical investigation : JMI·2025
Same author

[A Questionnaire Survey of Nurses on Pharmacist Services in the Emergency Rooms at Tokushukai Medical Group].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2024
Same author

Facilely Fabricated Zero-Bias Silicon-Based Plasmonic Photodetector in the Near-Infrared Region with a Schottky Barrier Properly Controlled by Nanoalloys.

ACS applied materials & interfaces·2024

Area of Science:

  • Nephrology
  • Clinical Nutrition
  • Biochemistry

Background:

  • Hyperphosphatemia and hyperparathyroidism are common in end-stage renal disease (ESRD).
  • These conditions are linked to severe complications including renal osteodystrophy, organ calcification, cardiovascular disease, and increased mortality.
  • Dietary management is essential for slowing renal failure progression.

Purpose of the Study:

  • To emphasize the importance of dietary phosphorus restriction in all stages of renal failure in adults.
  • To outline strategies for achieving phosphorus restriction through dietary modifications.
  • To establish critical phosphorus intake levels and target biochemical parameters for ESRD patients.

Main Methods:

  • Reviewing the impact of dietary protein and phosphorus restriction on renal failure progression.

Related Experiment Videos

  • Analyzing phosphorus absorption rates in dialysis patients with and without phosphate binders.
  • Evaluating phosphorus removal by conventional hemodialysis.
  • Calculating critical phosphorus intake thresholds based on protein intake and body weight.

    • Main Results:

    • Dietary phosphorus restriction is recommended at all stages of renal failure.
    • Phosphorus absorption can be reduced from 60-80% to 40% with phosphate binders.
    • Hemodialysis removes approximately 30 mmol of phosphorus per session.
    • A phosphorus intake of 750 mg/day is a critical value above which positive phosphorus balance may occur, corresponding to 45-50 g protein/day.
    • Target levels for calcium, phosphorus, calcium-x-phosphorus product, and parathyroid hormone are provided.

    Conclusions:

    • Strict dietary phosphorus restriction is vital for managing ESRD complications.
    • Integrating dietary changes with phosphate binders and hemodialysis is key to phosphorus control.
    • Achieving target biochemical levels can mitigate the adverse effects of hyperphosphatemia and hyperparathyroidism in ESRD.